Shaping the future
treatment of
immune-mediated
diseases

Attovia™ is advancing a new generation of precision biologics for patients with high unmet need across immune-mediated diseases.

At the core of our strategy is the ATTOBODY™ platform, a powerful, modular protein design platform to create novel complex biologic medicines.

We’re driven by one goal: to change what patients can expect from their treatments and from their futures.

Shaping the future
treatment of
immune-mediated
diseases

Attovia™ is advancing a new generation of precision biologics for patients with high unmet need across immune-mediated diseases.

At the core of our strategy is the ATTOBODY™ platform, a powerful, modular protein design platform to create novel complex biologic medicines.

We’re driven by one goal: to change what patients can expect from their treatments and from their futures.

Interested in learning more or discussing partnering opportunities?

Interested in learning more or discussing partnering opportunities?

Leading the way to breakthrough multispecifics

We are a team of veteran drug development leaders passionate about bringing new and improved medicines to patients.

Image of Tao Fu, Attovia CEO

Tao Fu, MBA, M.S.

Chief Executive Officer

Image of Steven Chan, Attovia CFO

Steven Chan

Chief Financial Officer

Hubert Chen, M.D., M.P.H.

Chief Medical Officer

Image of Zaneta Odrowaz, Attovia CBO

Zaneta Odrowaz, PhD

Chief Business Officer

Image of Dr. Petter Veiby, Attovia CSO

Petter Veiby

Chief Scientific Officer

Image of Dr. Hanjun Zhan, Attovia CTO

Hangjun Zhan, Ph.D.

Chief Technology Officer

Bora Han, Ph.D.

VP, Head of Preclinical Development

Image of Veit Schmelmer, Ph.D.

Veit Schmelmer, Ph.D.

VP, Project Management & Portfolio Strategy

Image of Tao Fu, Attovia CEO

Tao Fu, MBA, M.S.

Chief Executive Officer

Image of Steven Chan, Attovia CFO

Steven Chan

Chief Financial Officer

Hubert Chen, M.D., M.P.H.

Chief Medical Officer

Image of Zaneta Odrowaz, Attovia CBO

Zaneta Odrowaz, PhD

Chief Business Officer

Image of Dr. Petter Veiby, Attovia CSO

Petter Veiby

Chief Scientific Officer

Image of Dr. Hanjun Zhan, Attovia CTO

Hangjun Zhan, Ph.D.

Chief Technology Officer

Bora Han, Ph.D.

VP, Head of Preclinical Development

Image of Veit Schmelmer, Ph.D.

Veit Schmelmer, Ph.D.

VP, Project Management & Portfolio Strategy

Image of team of scientists developing attobody therapeutics

Start making a difference!

At Attovia, we value integrity, learning, performance, innovation, and collaboration. We work together, celebrate our successes together, and strive to make Attovia a place where everyone can grow.

Want to join the Attovia team? Let’s talk.

CURRENT OPPORTUNITIES
Image of team of scientists developing attobody therapeutics

Start making a difference!

At Attovia, we value integrity, learning, performance, innovation, and collaboration. We work together, celebrate our successes together, and strive to make Attovia a place where everyone can grow.

Want to join the Attovia team? Let’s talk.

CURRENT OPPORTUNITIES